Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Tenpoint Therapeutics Holding Limited
Entity

Tenpoint Therapeutics Holding Limited

Tracked across 1 events · 12 articles · First seen Aug 20, 2026 · Last active Aug 21, 2026

Sentiment
25
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 25
Business
Lupin VISUfarma licenses YUVEZZI in Europe
Lupin (company)'s wholly-owned subsidiary VISUfarma has entered into an exclusive licensing agreement with Visus Therapeutics Inc., a wholly-owned subsidiary of Tenpoint Therapeutics Holding Limited, to commercialize YUVEZZI, a once-daily eye drop for presbyopia, in the…
Impact: Tenpoint, as parent of Visus, benefits from the licensing deal through milestone payments and royalties, supporting its global commercialization of YUVEZZI. The partnership with Lupin's established European Union — European operations is a strategic step in expanding market access.
Aug 20, 2026 · 12 articles
Key Actions (2)
70 Tenpoint Therapeutics Holding Limited will receive milestone paymentsLupin VISUfarma licenses...
60 Tenpoint Therapeutics Holding Limited submitted MMA in UK United Kingdom — Medicines and Healthcare products Regulatory AgencyLupin VISUfarma licenses...
ERGEN INTELLIGENCE
Track Tenpoint Therapeutics Holding Limited live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.